Theranos Serves as a Cautionary Tale for Biotech Funding Post author:Sam Post published:March 15, 2018 Post category:BioPharma There are dangers in biotech funding and Theranos should serve as a warning. Source: BioSpace You Might Also Like Tax Reform: A War on Life Sciences Innovation December 11, 2017 Bay Area's Portola Rockets as the FDA Approves First and Only Anticoagulant for Hospitals June 25, 2017 FDA Demands Karyopharm Stop Enrollment of All Selinexor Trials March 12, 2017
Bay Area's Portola Rockets as the FDA Approves First and Only Anticoagulant for Hospitals June 25, 2017
